Nutrients, Dietary Supplements, and Nutriceuticals: Cost Analysis Versus Clinical Benefits

-15% su kodu: ENG15
392,68 
Įprasta kaina: 461,98 
-15% su kodu: ENG15
Kupono kodas: ENG15
Akcija baigiasi: 2025-03-03
-15% su kodu: ENG15
392,68 
Įprasta kaina: 461,98 
-15% su kodu: ENG15
Kupono kodas: ENG15
Akcija baigiasi: 2025-03-03
-15% su kodu: ENG15
2025-02-28 461.9800 InStock
Nemokamas pristatymas į paštomatus per 11-15 darbo dienų užsakymams nuo 10,00 

Knygos aprašymas

Nutrients, Dietary Supplements, and Nutriceuticals: Cost Analysis Versus Clinical Benefits provides the most current, concise, scientific appraisal and economic analysis (costs vs. benefit) of nutritional supplements and bioactive components (nutriceuticals) of foods in improving the quality of life. It fills a much-needed gap to have a single volume provide a synopsis of cost analysis of dietary supplements and nutritional products as well as therapies for treatment and prevention of disease. Chapters include emerging fields of science and important discoveries relating to early stages of new nutriceuticals in cancer prevention, prior to clinical trials. Written by international and national standing leaders in the field, Nutrients, Dietary Supplements, and Nutriceuticals: Cost Analysis Versus Clinical Benefits is essential reading for nutritionists, pharmacologists, health care professionals, research scientists, cancer workers, pathologists, molecular and cellular biochemists, physicians, general practitioners as well as those interested in diet and nutrition in disease resistance via immune regulation.

Informacija

Serija: Nutrition and Health
Leidėjas: Humana Press
Išleidimo metai: 2016
Knygos puslapių skaičius: 520
ISBN-10: 1493961845
ISBN-13: 9781493961849
Formatas: 254 x 178 x 28 mm. Knyga minkštu viršeliu
Kalba: Anglų

Pirkėjų atsiliepimai

Parašykite atsiliepimą apie „Nutrients, Dietary Supplements, and Nutriceuticals: Cost Analysis Versus Clinical Benefits“

Būtina įvertinti prekę

Goodreads reviews for „Nutrients, Dietary Supplements, and Nutriceuticals: Cost Analysis Versus Clinical Benefits“